Dr. Tripathy on the Development of Palbociclib in Breast Cancer

Article

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Related Content
Image of a person with a breast tumor

Making Breast Cancer Treatment Decisions After Endocrine Therapy

Bridget Hoyt
August 15th 2025
Article
Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
August 15th 2025
Podcast
Photo of a person in a bathroom holding their abdomen and mouth

Adding Aprepitant to Chemo Extends Non-Luminal Breast Cancer Survival

Bridget Hoyt
August 15th 2025
Article
The Vitals

Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

Lindsay Fischer
August 15th 2025
Podcast
Graphic of a person with a breast tumor

Awareness of Actionable Mutations Guides mBC Treatment Post-Endocrine

Bridget Hoyt
August 15th 2025
Article
Graphic of a breast with a tumor

Real-World Data Tie Early Breast Cancer ctDNA to Recurrence, Lower OS

Jax DiEugenio
August 15th 2025
Article